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domized and prospective non-randomized comparative clinical trials about the efficacy of lateral bone
augmentation prior to implant placement and their outcome regarding bone-width gain. MATERIAL
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tion of duplicate studies, data extraction and risk-of-bias assessment according to the Cochrane guidelines,
random-effects meta-analyses of Mean Differences (MD) or Relative Risks (RR) and their 95% CIs were
performed, followed by subgroup, meta-regression, and sensitivity analyses. RESULTS A total of 25
trials (16 randomized / 9 non-randomized) were identified, which included a total of 553 patients (42.2%
male; mean age of 43.9 years). In these included studies and populations, various modalities for primary
lateral bone augmentation rendered implant placement feasible. Bone width gain was significantly in-
versely associated with baseline bone width (pooled effect: -0.35 mm/mm; 95% CI: -0.63 to -0.07 mm;
p=0.01). % graft resorption demonstrated a correlation with patient age (36% /year, 95% CI: -0.62 to
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to autograft alone (MD: 1.06 mm; 95% CI: 0.21 to 1.92 mm; p=0.01). Barrier membrane did not yield
significant difference in terms of bone width gain (MD: -0.33 mm; 95% CI: -2.24 to 1.58 mm; p>0.05) and
graft resorption (MD: 0.84 mm; 95% CI: -1.42 to 3.09 mm; p>0.05). CONCLUSIONS Initially smaller
bone dimension favors larger bone width gain, which indicates that a severe lateral bone deficiency can
be effectively augmented applying primary lateral bone augmentation. Patients’ age and recipient site
(maxilla or mandible) seems to influence graft resorption. The addition of a xenograft can be helpful for
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Abstract 
Aim: The aim of the current systematic review was to critically appraise evidence from 
randomized and prospective non-randomized comparative clinical trials about the efficacy of lateral 
bone augmentation prior to implant placement and their outcome regarding bone-width gain.  
Material and Methods: Eight databases were searched until May 2018 for randomized and 
prospective non-randomized comparative trials on lateral bone augmentation prior to implant 
placement. After elimination of duplicate studies, data extraction and risk-of-bias assessment 
according to the Cochrane guidelines, random-effects meta-analyses of Mean Differences (MD) or 
Relative Risks (RR) and their 95% CIs were performed, followed by subgroup, meta-regression, and 
sensitivity analyses. 
Results: A total of 25 trials (16 randomized / 9 non-randomized) were identified, which included a 
total of 553 patients (42.2% male; mean age of 43.9 years). In these included studies and populations, 
various modalities for primary lateral bone augmentation rendered implant placement feasible. Small 
discrepancies were found between overall clinical and radiographic gain (pooled gains of 3.45 ± 1.18 
mm versus 2.90 ± 0.83 mm, respectively), but were not statistically significant. Bone width gain was 
significantly inversely associated with baseline bone width (pooled effect: -0.35 mm/mm; 95% CI: -
0.63 to -0.07 mm; p=0.01). % graft resorption demonstrated a correlation with patient age (36% /year, 
95% CI: -0.62 to -0.11 mm; p=0.01). The presence of xenograft added to autologous graft led to less 
resorption compared to autologous graft alone (MD: 1.06 mm; 95% CI: 0.21 to 1.92 mm; p=0.01). 
Barrier membrane did not yield significant difference in terms of bone width gain (MD: -0.33 mm; 95% 
CI: -2.24 to 1.58 mm; p>0.05) and graft resorption (MD: 0.84 mm; 95% CI: -1.42 to 3.09 mm; p>0.05). 
Conclusions: Initially smaller bone dimension are associated with larger bone width gain, which 
indicates that a severe lateral bone deficiency can be effectively augmented applying primary lateral 
bone augmentation. Both patients’ age and recipient site (maxilla or mandible) seem to influence graft 
resorption. The addition of a xenograft can be helpful in reducing graft resorption.  
Clinical Relevance:  
Scientific rationale for the study  
Whether solely primary lateral bone augmentation leads to sufficient ridge width for subsequent 
implant placement, is still scarcely reported in detail. 
Principal findings 
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Most of the studies (24 out of 25 included) reported that lateral bone augmentation allowed for 
subsequent implant placement. Nevertheless, only a small number of studies reported on the 
proportion of implants placed according to the planning/ the placement in a prosthetically ideal 
position, the need for a narrower implant diameter or the proportion of implants which needed 
additional bone augmentation procedures.  
 The ridge width gain is significantly influenced by the ridge width prior to augmentation. Furthermore, 
bone width gain and graft resorption are influenced by baseline ridge width, age and jaw. The 
presence of xenogeneic graft material seems favorable in terms of dimensional stability. 
Practical implications 
Primary lateral bone augmentation represents a predictable procedure in order to gain sufficient ridge 




K E Y W O R D S 
systematic review, dental implant, implant placement, lateral bone augmentation, primary bone 
augmentation, ridge width  
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1 | INTRODUCTION 
1.1 | Rationale 
Implant placement at edentulous areas with severe bone deficiencies often represents a challenging 
situation for clinicians. In order to correct bone dimensions insufficient for implant placement, 
numerous bone augmentation procedures have been described in the literature (Esposito, et al., 
2009; Jensen & Terheyden, 2009). Bone augmentation may be carried out prior to or simultaneous 
with implant placement. The choice whether or not primary bone augmentation is needed depends on 
a number of factors: the amount of bone lacking; the area within the dental arch; feasibility of implant 
placement in a proper position and with primary stability; the expected size of implant surface 
exposure at the time of implant placement. Available evidence demonstrates predictable correction of 
bone deficiencies using bone augmentation procedures (Benic & Hammerle, 2014). Moreover, 
implant survival rates are similar both for implants placed in pristine bone as well as for implants 
placed in augmented bone (Hammerle, Jung & Feloutzis, 2002). 
The use of a variety of materials and techniques has been published (Aghaloo & Moy, 2007; 
Chiapasco & Casentini, 2018; Donos, Mardas & Chadha, 2008). The materials applied encompass 
autologous bone, allogenic bone, xenogenic bone and synthetic bone substitute materials. All of these 
biomaterials have been applied as blocks or in particulated form. Autologous bone grafts are 
predominantly harvested from intraoral sources such as the mandibular ramus, the chin region, the 
maxillary tuberosity, and the nasal spine (Chappuis, et al., 2018; Cordaro, Amade & Cordaro, 2002; 
Cordaro, Torsello, Morcavallo & di Torresanto, 2011; Meijndert, Raghoebar, Meijer & Vissink, 2008; 
Tolstunov, 2009). When larger amounts of autologous bone are needed, extraoral sites are chosen 
including the iliac crest and the external plate of the calvarium (Chiapasco, Autelitano, Rabbiosi & 
Zaniboni, 2013; Chiapasco, Di Martino, Anello, Zaniboni & Romeo, 2015). Moreover, autologous and 
allogenic bone have been combined with bone substitute materials (Wang, Misch & Neiva, 2004). The 
reason for combining these materials is to expand the volume of grafting material available and to 
reduce the resorption of the transplanted autologous or allogenic bone. A clinical benefit of using 
allogenic bone, xenogenic bone or synthetic bone substitute materials is to reduce or completely 
avoid the morbidity associated with bone harvesting procedures. Growth factors such as rhBMP2 and 
enhancers such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) have been used alone or 
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in combination with the above-described materials (Badr, Coulthard, Alissa & Oliver, 2010; Barbu, et 
al., 2016; de Freitas, et al., 2013). 
A variety of techniques, such as ridge-splitting, guided bone regeneration (GBR) procedures, 
transplantation of autologous bone and application of bone substitute materials have been introduced 
(Chiapasco, et al., 2015; Costa, Pelegrine, Fagundes, Simoes & Taha, 2011; Hammerle, et al., 2002; 
Scipioni, Bruschi & Calesini, 1994; Urban, Nagursky & Lozada, 2011). They have shown positive 
results for the correction of bone defects in the alveolar ridge. So far, no material and/or technique 
demonstrated to be superior in terms of feasibility of implant placement and bone gain. 
Numerous publications investigated horizontal bone augmentation both prior to and 
simultaneous with implant placement (Sanz-Sanchez, Ortiz-Vigon, Sanz-Martin, Figuero & Sanz, 
2015). Most of the systematic reviews available have concomitantly addressed staged and 
simultaneous bone augmentation (Aghaloo & Moy, 2007; Esposito, et al., 2009; Sanz-Sanchez, et al., 
2015). Limited evidence exists regarding only primary horizontal bone augmentation. Furthermore, 
scarce information is available assessing different approaches – i.e. materials and/or techniques – 
with respect to their ability to successfully regenerate bony ridge defects prior to implant placement. 
The primary aim of the reconstruction of deficient ridges is to improve the ridge profile in order 
to facilitate subsequent prosthetic rehabilitation. The prosthetic procedure predominantly applied after 
bone augmentation is an implant-borne reconstruction. Hence, the success of primary bone 
augmentation procedures may be assessed by the feasibility of implant placement following bone 
healing.  
 
1.2 | Objectives 
The aim of the current systematic review was to critically appraise evidence from randomized and 
prospective non-randomized comparative clinical trials on humans about the efficacy of primary lateral 
bone augmentation prior to implant placement and the primary outcome of bone-width gain.  
 
2 | MATERIALS AND METHODS 
2.1 | Protocol, registration, and eligibility criteria 
The review protocol was developed a priori according to the PRISMA (Preferred Reporting Items for 
Systematic Review and Meta-Analyses) statement (Liberati, et al., 2009) and registered in 
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PROSPERO (International prospective register of systematic reviews; CRD42018093073). The 
Participants-Intervention-Comparison-Outcome-Study design (PICOS) framework was established as 
follows: Participants – patients in need of primary lateral bone augmentation for increasing bone width 
in order to place dental implants at one or more sites in either jaw; Intervention – primary lateral bone 
augmentation using different materials/techniques; Comparison – any material/technique other than 
the Intervention group; Outcome (primary) – amount (width) of alveolar ridge gained through the 
augmentation procedure (measured radiographically or clinically), which was defined as bone width at 
re-entry for implant insertion minus pre-augmentation bone width; and Study design – randomized 
and prospective non-randomized comparative clinical trials. Additional secondary outcomes included: 
(i) feasibility of implant placement after an adequate healing time (with or without additional bone 
augmentation at the time of implant placement); (ii) amount of bone graft resorbed (defined as bone 
width at re-entry for implant insertion minus immediate post-augmentation bone width); (iii) % bone 
graft resorption from the added graft (defined as the amount of bone graft resorbed divided by the 
post-augmentation width addition); (iv) adverse events at recipient site (such as infection, graft failure, 
wound dehiscence) or at donor site (nerve damage, infection); (v) Patient-Reported Outcome 
Measures (PROMS) (morbidity: swelling, pain); (vi) implant failure (defined either as need for implant 
removal or as salvageable complication / peri-implant disease); and (v) marginal bone level changes 
after implant insertion/loading. Positive values for the primary outcome of bone width gain indicate 
that the bone width was increased compared to baseline. Negative values for the secondary outcome 
of bone graft resorption indicate that the bone graft added during the augmentation procedure had 
been resorbed at the re-entry surgery where implant placement was planned. 
The focused question this systematic review answered was: “In patients presenting with insufficient 
alveolar ridge width for implant placement, does primary lateral bone augmentation lead to sufficient 
gain in bone width (to allow for subsequent implant placement)?" 
Excluded were clearly retrospective studies or studies with unclear design, case reports or 
case series, animal studies, pre-clinical, and non-clinical studies. No limitations were set regarding 
publication year, publication language, or publication type. 
 
2.2 | Information sources and search 
Electronic searches were performed in the following eight electronic general, open access, 
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regional and grey literature bibliographic databases: MEDLINE (searched via PubMed), Cochrane 
Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane 
Database of Abstracts of Reviews of Effects (DARE), Embase, Scopus, Web of Knowledge, and 
Virtual Health Library (including Bibliografia Brasileira de Odontologia and LILACS). Aditionally, 
Directory of Open Access Journals, Digital Dissertations (searched via UMI Proquest), metaRegister 
of Controlled Trials, WHO trials search portal and Google Scholar were searched manually. No 
search filters were applied other than trials on humans and dentistry, where available. Hand 
searching was also performed from the reference/citation lists of eligible studies and relevant 
systematic reviews for additional studies (Appendix 1). 
 
 
2.3 | Study selection 
Study selection was performed in duplicate by two authors (NN, HCL) independently. Any 
disagreement in the process was solved by discussion with the other two authors (SNP, CHFH). First 
the titles and then the abstracts of all studies derived from the search were screened against the 
inclusion criteria. If title or abstract did not provide sufficient information regarding exclusion of a study, 
the decision was based on the study’s full text.  
 
2.4 | Data items and data collection process 
Data extraction was made independently by two authors (NN, HCL) using pre-specified extraction 
tables covering study characteristics (design, setting, and country), patient characteristics (number, 
sex, age, systemic health, and smoking), intervention (graft, membrane, number of augmented 
sites/implants), and outcome measurements (follow-up, measurement method, primary/secondary 
outcome). Any disagreements were discussed with the other two authors (SNP, CHFH). 
 
2.5 | Risk of bias of individual studies 
Two authors (NN, HCL) independently evaluated the risk of bias of included studies and any 
disagreements were discussed with the other two authors (SNP, CHFH). Randomized trials were 
assessed with the Cochrane risk of bias tool (Higgins & Green, 2011) and non-randomized studies 
were assessed with the ROBINS-I (Risk Of Bias In Non-randomised Studies - of Interventions) tool 
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(Sterne, et al., 2016).  
 
2.6 | Summary measures and synthesis of results 
The Mean Difference (MD) for continuous variables and the Relative Risk (RR) for binary variables 
with their corresponding 95% Confidence Intervals (CIs) were chosen a priori for data synthesis of 
primary or secondary outcomes. As various patient-/, site-/, and graft-specific factors were assumed 
to influence the true effects of lateral bone augmentation, a random-effect model was a priori chosen 
in order to incorporate this variability and calculate the mean distribution of these effects. The Paule 
and Mandel variance estimator was chosen a priori instead of the 'DerSimonian and Laird', due to its 
improved performance (Veroniki, et al., 2016). 
The extent and impact of between-study heterogeneity was assessed by inspecting the forest 
plots and calculating the tau2 (absolute heterogeneity) and the I2 (relative heterogeneity), respectively; 
I2 defines the proportion of total variability in the result explained by heterogeneity, and not chance 
(Higgins & Green, 2011). Heterogeneity was roughly categorized as low, moderate and high 
according to I2 values of 25, 50, and 75 per cent, although the heterogeneity’s localization on the 
forest plot was also judged. Additionally, the 95 per cent CIs around tau2 and I2 were calculated 
(Ioannidis, Patsopoulos & Evangelou, 2007) to quantify uncertainty around these estimates. Ninety-
five per cent predictive intervals were calculated for meta-analyses of ≥3 trials to incorporate existing 
heterogeneity and provide a range of possible effects for a future clinical setting, which is crucial for 
the correct interpretation of random-effects meta-analyses (IntHout, Ioannidis, Rovers & Goeman, 
2016). All analyses were conducted in Stata SE version 14.2 (StataCorp LP, College Station, Texas, 
USA) by one author (SNP) with the data made freely available in Zenodo (Naenni, Hyun‐Chang Lim, 
Papageorgiou & Hämmerle, 2018). A two side P < 0.05 was considered significant for hypothesis-
testing, except for P < 0.10 used for tests of between-studies or between-subgroups heterogeneity 
(Ioannidis, 2008). 
 
2.7 | Risk of bias across studies and additional analyses 
Possible sources of heterogeneity were a-priori planned to be sought through mixed-effects subgroup 
analyses about the combination of different grafts and the use of a membrane. Furthermore, the 
following meta-analyses (corresponding to individual patient data cumulative meta-regressions) were 
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performed by meta-analyzing the regression coefficients that originated from re-analysis of available 
raw data: patient age, patient sex, jaw, mouth region, baseline bone width, healing time and donor 
site for autologous grafts. Additional analyses for subgroups, meta-regressions and reporting biases 
were planned, but were not conducted due to lack of available studies (Appendix 2). 
Robustness of the results was planned a priori to be checked with sensitivity analyses based 
on (i) inclusion/exclusion of non-randomized trials, (ii) inclusion only of studies with low risk of bias 
and (iii) improvement of the Grades of Recommendations, Assessment, Development, and Evaluation 
(GRADE) classification. 
The overall quality of clinical recommendations for all meta-analyzed outcomes was rated 
using the GRADE approach, as very low, low, moderate, or high (Guyatt, Oxman, Schunemann, 
Tugwell & Knottnerus, 2011) and a Summary of Findings table (Table 3) was constructed using the 
improved format proposed by Carrasco-Labra et al. (Carrasco-Labra, et al., 2016) and recent 
guidance on incorporating non-randomized studies (Schunemann, et al., 2018). The minimal clinical 
important (Norman, Sloan & Wyrwich, 2003) large and very large effects were defined as half, one, 
and two standard deviations (using the average standard deviation for an outcome across included 
studies), respectively. Arbitrary cut-offs of 1.5, 2.0, and 5.0 (Schünemann, Brożek, Guyatt & Oxman, 
2013) were adopted for RR. The produced forest plots were augmented with contours denoting the 
magnitude of the observed effects (Papageorgiou, 2014) to visually gauge heterogeneity, clinical 
relevance and imprecision. 
 
3 | RESULTS 
3.1 | Study selection 
The literature search yielded a total of 8167 hits, while 7 additional records were identified by hand 
searching (Fig. 1). After eliminating 1771 duplicates, the titles and abstracts of the remaining papers 
where scrutinized, leading to the exclusion of another 6332 records. Finally, 71 full texts were 
checked for eligibility with respect to the inclusion / exclusion criteria. Of these, 41 articles were 
excluded for various reasons, leaving 30 papers pertaining to 25 unique studies for inclusion in the 
present systematic review (Appendix 3). All but one included articles reported on feasibility of implant 
placement after healing times ranging from 3.0 to 8.1 months, whereas four out of these studies 
followed the inserted implants up to 10 years (Table 1b,c). 
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3.2 | Study characteristics  
The characteristics of the 25 included studies are descriptively analyzed in Table 1a. Sixteen studies 
(64%) were randomized clinical trials (13 with parallel and 3 with within-patient randomization), while 
the remaining 9 (36%) were non-randomized comparative studies (5 explicitly prospective and 4 with 
unclear design). Most studies were performed in a university setting (n=16; 64%), followed by 
hospitals (n=3; 12%), a private practice (n=1; 4%) and a combination of university and private practice 
(n=1; 4%). The included studies were conducted in fifteen different countries, encompassing a patient 
population of 553 individuals (all studies reported on the number of patients) with a mean age of 43.9 
years (data from 18 studies reporting on age), of whom 42.2% were male (from 18 studies reporting 
on sex). The recipient sites of the included studies were as follows: 9 studies solely in the maxilla (6 in 
the anterior area, 3 in either anterior and posterior areas), 3 studies solely in the posterior mandible, 7 
studies investigated in both jaws, whilst 6 studies did not report on the region investigated. After 
primary lateral augmentation, sites had been left for healing between 3.0 - 8.1 months before re-entry 
/ implant placement (Table 1b). At least 761 implants (15 studies reported on the number of implants) 
were placed in at least 574 sites (reported in 25 studies). Twenty-three studies reported clinically 
and/or radiographically measured bone width changes (Table 1a). Implant feasibility was reported in 
all but in one study (Table 1c), complications in 17 studies (Table 1d), implant survival rate in 4 
studies (Table 1b), implant success rate in 3 studies (Table 1b), PROMS in two studies and marginal 
bone loss in 2 studies (Table 1b). The other outcomes irrelevant to the present review included bone 
quality, ISQ value, peri-implant health, esthetic index, bone microstructure, bone volume, histologic 
outcomes, soft-tissue volume. 
 
3.3 | Risk of bias within studies 
The risk of bias for the included randomized trials was assessed using the Cochrane Risk of Bias tool 
and is presented in Fig. 2a and Appendix 4a. None of the included studies had an overall low risk of 
bias. Only two studies had no high risk of bias for any of the assessed domains (de Freitas, et al., 
2016; Eskan, et al., 2014) and were thus judged to have an overall unclear risk of bias. Only three 
studies presented more than 50% of low risk in all seven domains (Badr, et al., 2010; de Freitas, et al., 
2016; Eskan, et al., 2014) and eight studies presented more than 50% of unclear risk (Aarújo, 2016; 
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Antoun, Sitbon, Martinez & Missika, 2001; Caldwell, Mills, Finlayson & Mealey, 2015; Costa, et al., 
2011; Kheur, et al., 2018; Mazzocco, Nart, Cheung & Griffin, 2011; Pourabbas & Nezafati, 2007; 
Thoma, et al., 2018). The most problematic domains with high risk of bias were "missing or 
incomplete blinding", "incomplete outcome data" and "other sources of bias". Additionally, none of the 
identified studies had a pre-defined registered protocol and the risk for "selective outcome reporting" 
bias was unclear in all publications. 
The risk of bias for the included non-randomised studies according to the ROBINS-I tool is 
presented in Fig. 2b and Appendix 4b. None of the studies presented low level of overall bias (one for 
moderate bias (Beitlitum, Artzi & Nemcovsky, 2010), five for serious bias (Barbu, et al., 2016; Cordaro, 
et al., 2002; Maiorana, Beretta, Salina & Santoro, 2005; Shalash, et al., 2013; Urban, et al., 2011) and 
three for critical bias (Chiapasco, Abati, Romeo & Vogel, 1999; Dasmah, Thor, Ekestubbe, Sennerby 
& Rasmusson, 2013; Monje, et al., 2014). The domain “bias due to confounding” was a source for 
critical risk of bias for three studies with overall critical risk of bias (Chiapasco, et al., 1999; de Freitas, 
et al., 2016; Monje, et al., 2014). The domain “bias due to missing data” was judged as unclear in all 
studies. The domains “bias due to confounding” and “bias in measurement of outcomes” was judged 
as serious in more than 50% of the studies. 
 
3.4 | Results of individual studies and synthesis of results 
In general, a wide variability regarding materials and techniques investigated as well as parameters 
reported was observed in the included studies (Table 1a-d). All studies gave to some extent 
descriptive aggregate data of their results, while 9 studies [four randomized (Aarújo, 2016; Caldwell, 
et al., 2015; Meijndert, Raghoebar, Schupbach, Meijer & Vissink, 2005; Thoma, et al., 2018) and five 
non-randomized (Barbu, et al., 2016; Chiapasco, et al., 1999; Maiorana, et al., 2005; Monje, et al., 
2014; Urban, et al., 2011)] also provided raw data in tabular form within the published report. 
Available raw data were re-analyzed with generalized linear regression models and are reported in full 
in Appendices 5-13. 
 
3.5 | Synthesis of results 
Overall, bone width pre-augmentation measured 2.96mm (95% CI: 2.69 to 3.23; I2: 97%), whilst bone 
width post-augmentation measured 7.68mm (95% CI: 7.11 to 8.24; I2: 96%). Due to graft resorption (-
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1.33mm (95% CI: -1.78 to -0.88; I2: 93%), bone width at re-entry resulted in a mean of 6.36 mm (95% 
CI: 5.73 to 6.99 mm; I2: 98%). Thus, an overall mean bone width gain of 3.30mm (95% CI: 2.81 to 
3.79; I2: 97%) could be achieved (Table 1e). Data resulting from re-analysis of the seven studies that 
provided raw data (Aarújo, 2016; Chiapasco, et al., 1999; Cordaro, et al., 2011; Eskan, et al., 2014; 
Maiorana, et al., 2005; Mordenfeld, Johansson, Albrektsson & Hallman, 2014; Thoma, et al., 2018) 
resulted in very similar pooled averages (Table 1f). 
Only a limited number of factors could finally be analyzed with random-effects meta-analyses: (i) a 
comparison pertaining to the use of an autologous graft (AUG) versus a xenograft (XEN) mixed 
with/without AUG (Aarújo, 2016; Barbu, et al., 2016; Cordaro, et al., 2011; Maiorana, et al., 2005; 
Urban, et al., 2011) (Table 2a, Fig. 3a, b) and (ii) a comparison for lateral bone augmentation with or 
without the use of a membrane (Antoun, et al., 2001; Chiapasco, et al., 1999) (Table 2b; Fig. 3a, b). 
Meta-analysis on the use of XEN (with/without AUG) compared to the use of AUG alone 
(Table 2a, Fig. 3a) did not find a statistically significant difference in the amount of BW gain (Aarújo, 
2016; Barbu, et al., 2016; Cordaro, et al., 2011; Maiorana, et al., 2005; Urban, et al., 2011) (MD: 0.32 
mm; 95% CI: -0.19 to 0.83 mm; p>0.05). On the other hand, sites augmented with XEN (with/without 
AUG) showed significantly less absolute graft resorption compared to sites augmented with AUG 
alone (MD: 1.06 mm; 95% CI: 0.21 to 1.92 mm; p=0.01) (Fig. 3b), with moderate heterogeneity across 
studies (I2: 63%). This was also reflected by graft resorption compared to the amount of bone graft 
added to the site, where sites augmented with XEN (with/without AUG) resulted in 11.6% less 
resorption of the added graft compared to AUG alone (MD: 11.6%; 95% CI: 5.2 to 18.1%; p<0.001). 
The use of a membrane with lateral augmentation could be assessed in a meta-analysis of 
two studies (Antoun, et al., 2001; Chiapasco, et al., 1999) (Table 2b). No statistically significant 
advantage could be observed regarding neither BW gain (MD: -0.33 mm; 95% CI: -2.24 to 1.58 mm; 
p>0.05) nor absolute graft resorption (MD: 0.84 mm; 95% CI: -1.42 to 3.09 mm; p>0.05) with the use 
of a membrane compared to no membrane (Fig. 3a, b). 
Furthermore, meta-analysis of the regression coefficients from the raw data of each study 
listed in Appendices 5-13 was used to assess the effect on the outcome of lateral augmentation of the 
following patient-/ graft-/ or surgery-related factors: age, sex, jaw, region, baseline BW, healing time 
and donor site for AUG (Appendix 14a-c). Regarding BW gain, the single predicting factor was 
baseline BW, where sites with greater pre-augmentation BW tended to have less benefit (pooled 
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effect: -0.35 mm; 95% CI: -0.63 to -0.07 mm; p=0.01) (Appendix 14a). As far as absolute bone graft 
resorption is concerned, no significant modifying factor was identified, although there was a trend for 
maxillary sites to present greater post-augmentation resorption compared to mandibular sites (pooled 
effect: -0.21 mm; 95% CI: -0.47 to 0.05 mm; p=0.12) (Appendix 14b). Finally, as far as % bone graft 
resorption of the added graft is concerned, BW at baseline was again inversely associated with BW 
gain. Increased baseline BW of the site was associated with increased % resorption (pooled effect: -
4.7%; 95% CI: -9.9 to 0.5%; p=0.07) (Appendix 14c). Additionally, patient age had a significant 
influence, with older patients presenting higher % resorption (pooled effect: -0.4% per year; -0.6% to -
0.1% per year; p=0.01). 
 
3.6 | Additional analyses and Risk of bias across studies  
A large number of subgroup and meta-regression analyses had been initially planned, but could 
ultimately not be conducted (Appendix 2). The only subgroup analysis that could be performed 
pertained to the meta-analysis of BW gain with the use of an autologous graft (AUG) versus a 
xenograft (XEN) mixed with/without AUG (Table 2c; 5 studies). No statistically significant differences 
could be found when comparing (i) the use of XEN versus AUG and the use of XEN-AUG versus 
AUG or (ii) the use of a membrane or not. 
A sensitivity analysis was conducted by excluding non-randomized studies and including only 
randomized studies in the analysis (Appendix 15). The comparisons of lateral bone augmentation with 
AUG versus a xenograft XEN mixed with/without AUG were relative robust to the inclusion of only 
randomized trials, as still no statistically significant differences were found. On the other side, 
sensitivity analysis on membrane use gave slightly different results. For one, now the BW gain when 
using a membrane was greater compared to no membrane use. Nevertheless, this difference did not 
reach statistical significance. This was in contrast to the original analysis that showed the opposite 
(MDs of -0.33 mm for the original and 0.80 mm for the sensitivity analysis). Additionally, membrane 
use was associated with a significantly lower amount of post-augmentation graft resorption compared 
to no use of membrane (MD: 2.0 mm; 95% CI: 1.3 to 2.8 mm; p<0.001), which was contrary to the 
original analysis from randomized and non-randomized studies. 
The quality of evidence from all meta-analyses was finally gauged with the GRADE approach 
using the original analyses, except for the case of bone graft resorption with/without membrane, 
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where the sensitivity analysis was used (Table 3). All meta-analyses were judged to provide very low 
quality of evidence due to the inclusion of non-randomized studies, the high risk-of-bias of both 
randomized and non-randomized included studies, and imprecision due to limited sample sizes. The 
only exception was the sensitivity analysis assessing bone graft resorption with or without the use of 
membrane, where moderate quality of evidence favored membrane use—with the only limitation 
being the high risk-of.bias in the included randomized trial. 
 
4 | DISCUSSION 
4.1 | Summary of evidence 
The literature search yielded a total of 25 studies, of which 16 were randomized and 9 were non-
randomized comparative studies including at least 553 patients (mean age 43.9 years/ 42.2% male) 
and at least 761 dental implants that had been placed after a healing-time of 3.0-8.1 months following 
primary horizontal augmentation. 
The results of the current systematic showed that: i) feasibility of implant placement was 
achieved in the majority of the studies, although sometimes requiring additional GBR at the time of 
implant placement; ii) bone width (BW) gain was significantly influenced by BW at baseline; iii) age 
revealed a significant association with bone graft resorption favoring younger patients; iv) groups 
using xenograft showed significantly less graft resorption compared to autologous graft alone, but did 
not lead to a statistically significant difference in BW gain and v) the use of a membrane did not result 
in superior BW gain compared to augmentation without a membrane.   
 
Bone width gain 
This systematic review revealed that horizontal ridge augmentation prior to implant placement was 
successful in terms of BW gain. Nevertheless, some studies reported on the need for additional bone 
augmentation at the time of implant placement (Badr, et al., 2010; Beitlitum, et al., 2010; Chiapasco, 
et al., 1999; Kheur, et al., 2018; Meijndert, et al., 2005) or the need for the placement of a narrower 
implant diameter than planned (Eskan, et al., 2014). In case of insufficient ridge width after bone 
augmentation, the placement of a smaller diameter implant or a simultaneous bone augmentation 
might be considered. Interestingly, BW at baseline (prior to augmentation) was significantly inversely 
correlated with the obtained BW gain (see supplement 14a), which indicates that the thinner the 
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baseline BW was, the more BW gain could be achieved. This observation might be due to two 
potential reasons: i) the resorptive pattern may tend to follow the natural anatomy of the original ridge 
and/or ii) the more ridge width is present prior to augmentation, the less bone graft material is applied. 
One study demonstrated that bone augmentation within the bony envelope is highly 
predictable compared to that outside of the bony envelope (Tinti & Parma-Benfenati, 2003). Thus, 
when overbuilding is performed out of the ridge anatomy, one should consider the possibility of future 
resorption. However, there has been no long-term study to investigate this issue. 
Moreover, when performing a ridge augmentation procedure, it is important to know what 
amount of graft material is required depending on the prosthetic planning (Chiapasco & Casentini, 
2018). Within the present review, most of the authors seemed to aim at placing regular diameter 
implants ranging from 3.5 to 4.1 mm (Table 1c), which may indicate that 6-7 mm of BW could be 
considered sufficient for implant placement. If, for example 4 mm of residual BW is present (reported 
as baseline BW in some studies), there might be no reason to apply a great amount of bone graft 
material. As a consequence, the anticipated final BW has to be taken into account when performing 
ridge augmentation procedures, without disregarding expected resorptive processes. 
 
Implant feasibility 
Implant feasibility reflects the most important parameter in assessing the success of primary bone 
augmentation. Ideally, implant planning - such as prosthetically ideal positioning, implant diameter 
and length - should be determined preceding primary bone augmentation (Chiapasco & Casentini, 
2018). Based on the literature search, only one study reported specifically on pre-augmentation 
implant planning (Eskan, et al., 2014)(Table 1c). In that study, the predictability of planned implant 
placement reached 100% in one group and 93% in the other group. Eleven studies reported on 
implant diameter, although without giving further information regarding the placement thereafter. The 
rest of the included studies did not provide information regarding implant diameter. Authors used 
terms such as 'proper implant placement' and 'suitable sized implant'. The above-described main 
findings were not reported in a way that allowed for proper statistical analysis, but are reported in a 
descriptive manner within this investigation. Hence, the original primary aim of this systematic review 




Meta-analysis of the regression coefficients indicated a relationship between % graft resorption and 
patient age (P<0.01; Appendix 14c). Age has been controversially discussed as a factor influencing 
implant success (Bartold, Ivanovski & Darby, 2016; Ikebe, Wada, Kagawa & Maeda, 2009). 
Presumably older patients may exhibit poorer local bone condition, require longer healing periods and 
display more systematic diseases related to healing potential in general. Based on the meta-analysis, 
this review revealed that every additional year of age at the time of primary augmentation led to 0.05 
mm (95% CI: -0.03 to 0.12 mm; p=0.20) more absolute resorption of the augmented bone (Appendix 
14b). For example, a 60-year old patient would experience 1 mm more graft resorption post-
augmentation compared to a 40-year old patient. This age-dependent resorptive pattern could 
perhaps become more clinically relevant due to current aged or ultra-aged society (Muramatsu & 
Akiyama, 2011). 
Regarding the outcomes for the recipient jaw, results were potentially in favor of the mandible. 
Thus, absolute graft resorption was more pronounced in the maxilla (difference: -0.21 mm; 95% CI: -
0.47 to 0.05 mm), even though this was not statistically significant (p=0.12), probably due to low 
power (Appendix 14b). Possible cause-effectors might be the level of surgical difficulty especially in 
the posterior maxilla, extensive overbuilding in the anterior maxilla or uneven pressure of soft tissue 
after closure of the flap. One might initially expect that extensively resorbed mostly cortical mandibles 
might yield unfavorable augmentation results due to reduced vascularization. However, radiographic 
evidence indicates that the blood vessels remain within the central canals of resorbed osteons and 
even the densest-appearing cortex is actually porous (Atwood, 1962).  
 
Presence of xenograft 
The presence of a xenograft lead to decreased graft resorption compared to autologous grafts alone. 
These results seem somehow contradictory, originating from 5 studies for BW gain (showing no 
significance) compared to 3 studies having been analyzed for graft resorption. Three authors (Barbu, 
et al., 2016; Cordaro, et al., 2011; Maiorana, et al., 2005) have used the autologous block with 
particulated xenogenic graft material ("added at the periphery", "in order to fill gaps and defects" and 
"over the graft"), whereas one study had used particulated autologous graft mixed with particulated 
xenograft in a 1:1 ratio (Urban, et al., 2011) and one had used a xenograft block alone (Aarújo, 2016). 
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Sites augmented with xenogeneic graft materials with or without autologous bone particles XEN 
(with/without AUG) revealed 11.6% less resorption compared to sites augmented with autologous 
grafts alone AUG (MD: 11.6%; 95% CI: 5.2 to 18.1%; p<0.001) (Table 2a). These results support the 
assumption that the presence of a xenograft prevents from bone resorption. This might be due to its 
slow resorption rate and thus long standing-time (Schlegel & Donath, 1998; Skoglund, Hising & 
Young, 1997). 
 
Use of membrane 
Although the use of a membrane is supposed to prevent soft tissue ingrowth (Dahlin, Linde, Gottlow 
& Nyman, 1988; Kostopoulos & Karring, 1994), augmentation without membrane coverage did not 
demonstrate significant differences in terms of BW gain and graft resorption within this study. The two 
studies investigating the use of a non-resorbable membrane (Antoun, et al., 2001; Chiapasco, et al., 
1999) applied an autologous block bone graft without a membrane and compared this treatment with 
either a GBR procedure (particulated autologous bone and membrane) or an autologous block graft 
with membrane coverage.  These results were to some extent unexpected. A wide body of evidence 
exists on the procedure of bone augmentation and the use of membranes in order to maintain space, 
prevent soft tissue ingrowth and to help stabilize the augmented area. This may have played a minor 
role in the two before-mentioned studies, as bone block grafts were used. The cortical layer of the 
bone block might be sufficient to prevent soft tissue ingrowth and resist to resorption. Additionally, the 
fixating screws may have given the bone block graft sufficient stability. Evidence regarding no need to 
use a membrane shall be perceived whilst keeping this in mind. 
 
Bone width measurements 
Bone width gain was measured in the included studies either clinically and/or radiographically, while 
only one study transparently provided results of both clinical and radiographic measurements (de 
Freitas et al., 2013). Although small discrepancies were found between overall clinical and 
radiographic gain (pooled gains of 3.45 ± 1.18 mm versus 2.90 ± 0.83 mm, respectively), these were 
not statistically significant. However, both the bone gain magnitude and the variation of the 
measurements (seen through the standard deviation) was consistently lower radiographically than 
clinically, which might indicate greater measurement accuracy for the radiographic method. 
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Additionally, radiographic evaluation of bone width enables a more comprehensive assessment of the 
alveolar width at different heights. For example, the same study (de Freitas et al., 2013) reported 
considerable differences in bone width gain according to height below the alveolar crest (pooled 
gains: 1.00 ± 0.94 mm 2 mm below crest, 2.90 ± 0.83 mm 6 mm below crest, and 1.75 ± 0.98 mm 10 
mm below crest). This indicates a possibly uneven pattern of post-augmentation resorption and final 
bone width gain that might have a direct clinical relevance and is therefore an interesting aspect for 
future research. 
 
4.2 | Strengths and limitations 
The strengths of this systematic review consist of the registration of its a priori protocol in 
PROSPERO (Sideri, Papageorgiou & Eliades, 2018), its exhaustive literature search, its improved 
analytical methods (Veroniki, et al., 2016), the use of the GRADE approach (Guyatt, et al., 2011) to 
assess the quality of the meta-evidence, and the transparent provision of the study’s data (Naenni, et 
al., 2018). Additionally, only randomized and prospective non-randomized comparative studies were 
included in this systematic review, which are less biased than retrospective non-randomized studies. 
However, certain limitations do exist mainly due to the vast methodological and clinical 
heterogeneity of the identified studies. First, the initially planned primary outcome of the review 
pertaining to implant feasibility was discarded as the primary outcome, since no study but one 
transparently reported on deviations from implant size that was originally planned and implant size 
that was eventually inserted. Results on feasibility are reported as secondary outcomes and in a 
descriptive manner. Second, data on post-augmentation BW gain were measured in the identified 
studies (Beitlitum, et al., 2010; de Freitas, et al., 2013; de Freitas, et al., 2016; Mazzocco, et al., 2011) 
either clinically or radiographically, although hints exist that the measurement method might have a 
direct influence on the observed BW. Third, a few secondary outcomes could not be statistically 
analyzed due to study characteristics and thus are only descriptively reported within this review. Peri-
implant health would have been an outcome of most interest, especially in implants placed after 
primary lateral augmentation. Unfortunately, only two of the included studies investigated this 
parameter (Cordaro, et al., 2011; Meijndert, et al., 2017). Furthermore, methodological issues existed 
for all included studies, as has been often reported for clinical trials in implant dentistry (Papageorgiou, 
Kloukos, Petridis & Pandis, 2015), and these might have influenced the review’s results. This is 
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especially the case for included non-randomized studies that were not clearly retrospective and not 
clearly prospective—even though a sensitivity analysis of only randomized studies indicated 
robustness of the results. Furthermore, the identified studies reported predominantly on small sample 
sizes and this might have introduced small-study effects (Cappelleri, et al., 1996). Also, analysis was 
performed on augmentation site level, which ignores clustering effects and might lead to information 
loss, except for studies where full data were openly available and were analyzed appropriately 
(Appendix 5-13). The limited number of included studies and their suboptimal reporting did not enable 
robust assessments of heterogeneity, as well as the conduct of several analyses for subgroup, and 
small-study effects that were planned. Finally, no formal assessment of reporting biases was possible 
due to the small number of included studies and the lack of published trial protocols, even though our 
comprehensive and unrestricted literature search might partially safeguard against reporting bias. 
 
5 | CONCLUSIONS 
Based on the results from the included randomized and prospective non-randomized trials, primary 
lateral bone augmentation leads to sufficient bone width and allows for subsequent implant placement 
in most cases. In general, initially smaller bone dimension is associated with larger bone width gain, 
which indicates that a severe lateral bone deficiency can be effectively augmented applying primary 
lateral bone augmentation. Patients’ age and recipient site (maxilla or mandible) seems to influence 
graft resorption. The addition of a xenograft can be helpful for reducing graft resorption. However, the 
quality of clinical recommendation that can be drawn at the present time ranges from moderate to 
very low, due to the limited number of existing studies and their methodological shortcomings. 
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Figure 1. Flow diagram for the identification and selection of eligible studies for this systematic review. 
 * descriptive data were missing to include the studies in the analyses. 
 
Figure 2a. Risk of bias summary of included randomized trials with the Cochrane risk of bias tool. 
  2b. Risk of bias summary of included non-randomized trials with the ROBINS-I tool. 
 
Figure 3a. Contour-enhanced forest plot on the amount of bone width gained from lateral 
 augmentation. AUG, autologous graft; CI, confidence interval; MD, mean difference; WO/W, 
 with/without; XEN, xenograft. 
  3b. Contour-enhanced forest plot on the amount of graft resorption during lateral 
 augmentation. AUG, autologous graft; CI, confidence interval; MD, mean difference; WO/W, 





Table 1a. Characteristics of included studies.  
* countries are given with their ISO Alpha-3 codes 
† age is given in years as either mean (one value) or if mean not reported as range (two values in 
parenthesis) 
§ excluding two patients being in both groups from the age-counting 
ALG: allogenic graft; ALP: alloplastic grafts; ANT: anterior; AUG: autologous graft; G1,G2: group 1, 
group 2; hosp: hospital; Max: maxilla; MC: Multi-center; MEM: membrane; Mnd: mandible; NR: not 
reported; NRES: non-resorbable; Pats: patient; pNRS: prospective non-randomized study; POS: 
posterior; pract: private practice; pRCT: parallel randomized clinical trial; PRF: platelet-rich fibrin; 
PRP: platelet-rich plasma; RE: ridge expansion; RES: resorbable; RS: ridge-splitting; SD: systemic 
disease; Univ: university clinic; uNRS: non-randomized study with unclear design; wpRCT: within-
person randomized clinical trial; XEN: xenograft. 
 
Table 1b. Outcomes assessed by included studies. 
‡ follow-up after augmentation is given in months as either mean (one value) or if mean not reported 
as range  
§ two patients are in both groups 
BW: bone width; BQ: bone quality; CLIN: clinical; CoI: Conflict of Interest; Compl: Complication; FU: 
follow-up; Imp: implantation; ImpIns: implantation insertion; Imp success: Implant success; Imp 
survival: Implant survival; NR: not reported; RAD: radiography. 
 
Table 1c. Implant information by included studies. 
placed: Number of implants placed; planned: Number of implants planned; Implant diameter: Implant 
diameter in mm; additional GBR at the time of implant placement: Guided bone regeneration (GBR) 
performed at the time of implant placement; Comment: Additional information given by the authors. 
  
 
Table 2a. Random-effects meta-analyses on use of xenograft for lateral augmentation (experimental) 
compared to use of autologous graft (reference). 
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BW: bone width; CI: confidence interval; MD: mean difference; NC: non calculable. 
 
Table 2b. Random-effects meta-analyses on membrane use during lateral augmentation 
(experimental) compared to no membrane use (reference). 
BW: bone width; CI: confidence interval; MD: mean difference; NC: non calculable. 
 
Table 2c. Subgroup analysis for the meta-analysis on use of xenograft for lateral augmentation 
(experimental) compared to use of autologous graft (reference) and with the outcome of bone width 
gain. 
AUG: autologous graft; CI: confidence interval; MD: mean difference; XEN: xenograft. 
 
Table 3. Summary of findings table according to the Grades of Recommendations, Assessment, 
Development, and Evaluation (GRADE) approach. 
Factors associated with outcome of lateral bone augmentation. 
Population & intervention: partially/fully edentulous adult patients with resorbed alveolar bone 
receiving lateral bone augmentation prior to dental implant treatment. 
Settings: university clinics and private practice. 
a The basis for the risk in the control group (e.g., the median control group risk across studies) 
is provided in footnotes. The risk in the intervention group (and its 95% confidence interval) is based 
on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% 
CI). 
b Reponse in the control group is based on pooled Paule-Mandel meta-analyzed effect in the 
control group. 
c GRADE for both randomized and non-randomized studies starts from “high”. 
d Downgraded initially to ‘low’ due to the inclusion of non-randomized studies; further 
downgraded to very low for lack of blinding serious limitations (high risk of bias). 
e Imprecision also identified due to the limited sample size finally included; however GRADE is 
already at very low. 
f The single identified trial was in high risk of bias due to incomplete reporting of data; 
downgraded by one. 
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CI: confidence interval; CTR: control category; EXP: experimental category; GRADE: Grading of 
Recommendations Assessment, Development and Evaluation; MD: mean difference. 
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